Loading…

Human rabies post exposure prophylaxis at the Pasteur Institute of Dakar, Senegal: trends and risk factors

Rabies remains a major public health problem in developing countries. Most fatal rabies cases, especially in children, result from dog bites and occur in low-income countries, such as those in Sub-Saharan Africa. Rabies can be controlled through mass dog vaccination and human deaths prevented throug...

Full description

Saved in:
Bibliographic Details
Published in:BMC infectious diseases 2019-04, Vol.19 (1), p.321-9, Article 321
Main Authors: Diallo, Mamadou Korka, Diallo, Alpha Oumar, Dicko, Anta, Richard, Vincent, Espié, Emmanuelle
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c628t-a9c6fdae3eacf1d25f55a221a6be6936b53038fcdfd4d71901e9d71bd9c4c0013
cites cdi_FETCH-LOGICAL-c628t-a9c6fdae3eacf1d25f55a221a6be6936b53038fcdfd4d71901e9d71bd9c4c0013
container_end_page 9
container_issue 1
container_start_page 321
container_title BMC infectious diseases
container_volume 19
creator Diallo, Mamadou Korka
Diallo, Alpha Oumar
Dicko, Anta
Richard, Vincent
Espié, Emmanuelle
description Rabies remains a major public health problem in developing countries. Most fatal rabies cases, especially in children, result from dog bites and occur in low-income countries, such as those in Sub-Saharan Africa. Rabies can be controlled through mass dog vaccination and human deaths prevented through timely and appropriate post-exposure prophylaxis (PEP). As access to appropriate PEP remains a serious challenge for bite-victims, the aim of this study was to understand the use of PEP, to evaluate the knowledge, attitudes and practices with respect to rabies and to identify risk factors related to non-compliance with PEP to define recommendations for improving PEP in Senegal. This study included patients with suspicion of rabies exposure who sought PEP at the Pasteur Institute of Dakar from April 2013 to March 2014. Patients with rabies clinical symptoms, those who had already started PEP and those with exposure outside Senegal or for more than 3 months were excluded. Data on risk factors and propensity to seek and complete PEP were collected using questionnaires and phone interviews. The association between acceptability and compliance with PEP and other independent variables were evaluated using multivariate regression analysis. Among the 905 patients enrolled into the study, 67% were male (sex ratio M/F, 2) and 46%, children under 15 years of age. Exposures by animal bites represented 87%, whereas the remainder were due to scratches or contact; 76% were classified as WHO category III and 88% were due to dogs. Among these patients, 7% refused to start PEP and 54.5% completed the full schedule. Main factors reported by non-compliant patients were vaccine costs and affordability, and knowledge on status of biting animal. This study shows that despite the awareness about rabies dangers and prevention, only half of the patients completed the full PEP schedule. The following recommendations, such as free of charge prophylaxis or intradermal regimens as an alternative to intramuscular regimens, should be considered to increase the adherence to PEP at the Pasteur Institute of Dakar and in Senegal.
doi_str_mv 10.1186/s12879-019-3928-0
format article
fullrecord <record><control><sourceid>gale_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_598ac729ef6c473492f597fa47635088</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A583177464</galeid><doaj_id>oai_doaj_org_article_598ac729ef6c473492f597fa47635088</doaj_id><sourcerecordid>A583177464</sourcerecordid><originalsourceid>FETCH-LOGICAL-c628t-a9c6fdae3eacf1d25f55a221a6be6936b53038fcdfd4d71901e9d71bd9c4c0013</originalsourceid><addsrcrecordid>eNqNkktv1DAURiMEolD4AWyQJTYgkeJH4gcLpKo8OlKlIgpsrTvO9TTTTDzYDmr_PZ5OKR3EAnlxLefc4_jqq6pnjB4wpuWbxLhWpqbM1MJwXdN71SPWKFZzIZr7d_Z71eOUlpQypbl5WO0JalRLjX5ULY-nFYwkwrzHRNYhZYKXpUwRyTqG9fnVAJd9IpBJPkfyGVLGKZLZmHKfp4wkePIeLiC-Jmc44gKGtyRHHLvSMnYk9umCeHA5xPSkeuBhSPj0pu5X3z5--Hp0XJ-cfpodHZ7UTnKdazBO-g5QIDjPOt76tgXOGcg5SiPkvBVUaO863zWdYoYyNKXOO-MaV54o9qvZ1tsFWNp17FcQr2yA3l4fhLiwEHPvBrSt0eAUN-ila5RoDPetUR4aJUVLtS6ud1vXepqvsHM45gjDjnT3y9if20X4aWUjactEEby8EcTwY8KU7apPDocBRgxTspxTU_6CyaagL_5Cl2GKYxlVoVhxaSXpH6qMGm0_-lDudRupPWy1YEo1166Df1BldbjqXRjR9-V8p-HVTkNhMl7mBUwp2dnZl_9nT7_vsmzLuhhSiuhvZ8eo3YTYbkNsS4jtJsR288Tnd4d-2_E7teIXPMfqrw</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2211338760</pqid></control><display><type>article</type><title>Human rabies post exposure prophylaxis at the Pasteur Institute of Dakar, Senegal: trends and risk factors</title><source>Publicly Available Content Database</source><source>PubMed Central</source><creator>Diallo, Mamadou Korka ; Diallo, Alpha Oumar ; Dicko, Anta ; Richard, Vincent ; Espié, Emmanuelle</creator><creatorcontrib>Diallo, Mamadou Korka ; Diallo, Alpha Oumar ; Dicko, Anta ; Richard, Vincent ; Espié, Emmanuelle</creatorcontrib><description>Rabies remains a major public health problem in developing countries. Most fatal rabies cases, especially in children, result from dog bites and occur in low-income countries, such as those in Sub-Saharan Africa. Rabies can be controlled through mass dog vaccination and human deaths prevented through timely and appropriate post-exposure prophylaxis (PEP). As access to appropriate PEP remains a serious challenge for bite-victims, the aim of this study was to understand the use of PEP, to evaluate the knowledge, attitudes and practices with respect to rabies and to identify risk factors related to non-compliance with PEP to define recommendations for improving PEP in Senegal. This study included patients with suspicion of rabies exposure who sought PEP at the Pasteur Institute of Dakar from April 2013 to March 2014. Patients with rabies clinical symptoms, those who had already started PEP and those with exposure outside Senegal or for more than 3 months were excluded. Data on risk factors and propensity to seek and complete PEP were collected using questionnaires and phone interviews. The association between acceptability and compliance with PEP and other independent variables were evaluated using multivariate regression analysis. Among the 905 patients enrolled into the study, 67% were male (sex ratio M/F, 2) and 46%, children under 15 years of age. Exposures by animal bites represented 87%, whereas the remainder were due to scratches or contact; 76% were classified as WHO category III and 88% were due to dogs. Among these patients, 7% refused to start PEP and 54.5% completed the full schedule. Main factors reported by non-compliant patients were vaccine costs and affordability, and knowledge on status of biting animal. This study shows that despite the awareness about rabies dangers and prevention, only half of the patients completed the full PEP schedule. The following recommendations, such as free of charge prophylaxis or intradermal regimens as an alternative to intramuscular regimens, should be considered to increase the adherence to PEP at the Pasteur Institute of Dakar and in Senegal.</description><identifier>ISSN: 1471-2334</identifier><identifier>EISSN: 1471-2334</identifier><identifier>DOI: 10.1186/s12879-019-3928-0</identifier><identifier>PMID: 30975098</identifier><language>eng</language><publisher>England: BioMed Central Ltd</publisher><subject>Adolescent ; Adult ; Aged ; Aged, 80 and over ; Analysis ; Animal bites ; Animals ; Bites (Injuries) ; Bites and Stings ; Biting ; Child ; Child, Preschool ; Children ; Cohort Studies ; Costs and Cost Analysis ; Developing Countries ; Dog bites ; Dogs ; Exposure ; Female ; Health Knowledge, Attitudes, Practice ; Humans ; Immunization ; Independent variables ; Infant ; Infectious diseases ; Knowledge ; LDCs ; Male ; Medical research ; Middle Aged ; Patient Compliance ; Patients ; Post exposure prophylaxis ; Post-Exposure Prophylaxis - methods ; Post-Exposure Prophylaxis - trends ; Prophylaxis ; Prospective Studies ; Public health ; Questionnaires ; Rabies ; Rabies - prevention &amp; control ; Rabies Vaccines - economics ; Rabies Vaccines - therapeutic use ; Regression analysis ; Risk analysis ; Risk Factors ; Schedules ; Senegal ; Sex ratio ; Signs and symptoms ; Statistical analysis ; Sub-saharan Africa ; Tropical diseases ; Vaccination ; Vaccines ; Young Adult</subject><ispartof>BMC infectious diseases, 2019-04, Vol.19 (1), p.321-9, Article 321</ispartof><rights>COPYRIGHT 2019 BioMed Central Ltd.</rights><rights>2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>The Author(s). 2019</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c628t-a9c6fdae3eacf1d25f55a221a6be6936b53038fcdfd4d71901e9d71bd9c4c0013</citedby><cites>FETCH-LOGICAL-c628t-a9c6fdae3eacf1d25f55a221a6be6936b53038fcdfd4d71901e9d71bd9c4c0013</cites><orcidid>0000-0001-8697-7880</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6460513/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2211338760?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27924,27925,37012,37013,44590,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30975098$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Diallo, Mamadou Korka</creatorcontrib><creatorcontrib>Diallo, Alpha Oumar</creatorcontrib><creatorcontrib>Dicko, Anta</creatorcontrib><creatorcontrib>Richard, Vincent</creatorcontrib><creatorcontrib>Espié, Emmanuelle</creatorcontrib><title>Human rabies post exposure prophylaxis at the Pasteur Institute of Dakar, Senegal: trends and risk factors</title><title>BMC infectious diseases</title><addtitle>BMC Infect Dis</addtitle><description>Rabies remains a major public health problem in developing countries. Most fatal rabies cases, especially in children, result from dog bites and occur in low-income countries, such as those in Sub-Saharan Africa. Rabies can be controlled through mass dog vaccination and human deaths prevented through timely and appropriate post-exposure prophylaxis (PEP). As access to appropriate PEP remains a serious challenge for bite-victims, the aim of this study was to understand the use of PEP, to evaluate the knowledge, attitudes and practices with respect to rabies and to identify risk factors related to non-compliance with PEP to define recommendations for improving PEP in Senegal. This study included patients with suspicion of rabies exposure who sought PEP at the Pasteur Institute of Dakar from April 2013 to March 2014. Patients with rabies clinical symptoms, those who had already started PEP and those with exposure outside Senegal or for more than 3 months were excluded. Data on risk factors and propensity to seek and complete PEP were collected using questionnaires and phone interviews. The association between acceptability and compliance with PEP and other independent variables were evaluated using multivariate regression analysis. Among the 905 patients enrolled into the study, 67% were male (sex ratio M/F, 2) and 46%, children under 15 years of age. Exposures by animal bites represented 87%, whereas the remainder were due to scratches or contact; 76% were classified as WHO category III and 88% were due to dogs. Among these patients, 7% refused to start PEP and 54.5% completed the full schedule. Main factors reported by non-compliant patients were vaccine costs and affordability, and knowledge on status of biting animal. This study shows that despite the awareness about rabies dangers and prevention, only half of the patients completed the full PEP schedule. The following recommendations, such as free of charge prophylaxis or intradermal regimens as an alternative to intramuscular regimens, should be considered to increase the adherence to PEP at the Pasteur Institute of Dakar and in Senegal.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Analysis</subject><subject>Animal bites</subject><subject>Animals</subject><subject>Bites (Injuries)</subject><subject>Bites and Stings</subject><subject>Biting</subject><subject>Child</subject><subject>Child, Preschool</subject><subject>Children</subject><subject>Cohort Studies</subject><subject>Costs and Cost Analysis</subject><subject>Developing Countries</subject><subject>Dog bites</subject><subject>Dogs</subject><subject>Exposure</subject><subject>Female</subject><subject>Health Knowledge, Attitudes, Practice</subject><subject>Humans</subject><subject>Immunization</subject><subject>Independent variables</subject><subject>Infant</subject><subject>Infectious diseases</subject><subject>Knowledge</subject><subject>LDCs</subject><subject>Male</subject><subject>Medical research</subject><subject>Middle Aged</subject><subject>Patient Compliance</subject><subject>Patients</subject><subject>Post exposure prophylaxis</subject><subject>Post-Exposure Prophylaxis - methods</subject><subject>Post-Exposure Prophylaxis - trends</subject><subject>Prophylaxis</subject><subject>Prospective Studies</subject><subject>Public health</subject><subject>Questionnaires</subject><subject>Rabies</subject><subject>Rabies - prevention &amp; control</subject><subject>Rabies Vaccines - economics</subject><subject>Rabies Vaccines - therapeutic use</subject><subject>Regression analysis</subject><subject>Risk analysis</subject><subject>Risk Factors</subject><subject>Schedules</subject><subject>Senegal</subject><subject>Sex ratio</subject><subject>Signs and symptoms</subject><subject>Statistical analysis</subject><subject>Sub-saharan Africa</subject><subject>Tropical diseases</subject><subject>Vaccination</subject><subject>Vaccines</subject><subject>Young Adult</subject><issn>1471-2334</issn><issn>1471-2334</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNqNkktv1DAURiMEolD4AWyQJTYgkeJH4gcLpKo8OlKlIgpsrTvO9TTTTDzYDmr_PZ5OKR3EAnlxLefc4_jqq6pnjB4wpuWbxLhWpqbM1MJwXdN71SPWKFZzIZr7d_Z71eOUlpQypbl5WO0JalRLjX5ULY-nFYwkwrzHRNYhZYKXpUwRyTqG9fnVAJd9IpBJPkfyGVLGKZLZmHKfp4wkePIeLiC-Jmc44gKGtyRHHLvSMnYk9umCeHA5xPSkeuBhSPj0pu5X3z5--Hp0XJ-cfpodHZ7UTnKdazBO-g5QIDjPOt76tgXOGcg5SiPkvBVUaO863zWdYoYyNKXOO-MaV54o9qvZ1tsFWNp17FcQr2yA3l4fhLiwEHPvBrSt0eAUN-ila5RoDPetUR4aJUVLtS6ud1vXepqvsHM45gjDjnT3y9if20X4aWUjactEEby8EcTwY8KU7apPDocBRgxTspxTU_6CyaagL_5Cl2GKYxlVoVhxaSXpH6qMGm0_-lDudRupPWy1YEo1166Df1BldbjqXRjR9-V8p-HVTkNhMl7mBUwp2dnZl_9nT7_vsmzLuhhSiuhvZ8eo3YTYbkNsS4jtJsR288Tnd4d-2_E7teIXPMfqrw</recordid><startdate>20190411</startdate><enddate>20190411</enddate><creator>Diallo, Mamadou Korka</creator><creator>Diallo, Alpha Oumar</creator><creator>Dicko, Anta</creator><creator>Richard, Vincent</creator><creator>Espié, Emmanuelle</creator><general>BioMed Central Ltd</general><general>BioMed Central</general><general>BMC</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>IOV</scope><scope>ISR</scope><scope>3V.</scope><scope>7QL</scope><scope>7T2</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0001-8697-7880</orcidid></search><sort><creationdate>20190411</creationdate><title>Human rabies post exposure prophylaxis at the Pasteur Institute of Dakar, Senegal: trends and risk factors</title><author>Diallo, Mamadou Korka ; Diallo, Alpha Oumar ; Dicko, Anta ; Richard, Vincent ; Espié, Emmanuelle</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c628t-a9c6fdae3eacf1d25f55a221a6be6936b53038fcdfd4d71901e9d71bd9c4c0013</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Analysis</topic><topic>Animal bites</topic><topic>Animals</topic><topic>Bites (Injuries)</topic><topic>Bites and Stings</topic><topic>Biting</topic><topic>Child</topic><topic>Child, Preschool</topic><topic>Children</topic><topic>Cohort Studies</topic><topic>Costs and Cost Analysis</topic><topic>Developing Countries</topic><topic>Dog bites</topic><topic>Dogs</topic><topic>Exposure</topic><topic>Female</topic><topic>Health Knowledge, Attitudes, Practice</topic><topic>Humans</topic><topic>Immunization</topic><topic>Independent variables</topic><topic>Infant</topic><topic>Infectious diseases</topic><topic>Knowledge</topic><topic>LDCs</topic><topic>Male</topic><topic>Medical research</topic><topic>Middle Aged</topic><topic>Patient Compliance</topic><topic>Patients</topic><topic>Post exposure prophylaxis</topic><topic>Post-Exposure Prophylaxis - methods</topic><topic>Post-Exposure Prophylaxis - trends</topic><topic>Prophylaxis</topic><topic>Prospective Studies</topic><topic>Public health</topic><topic>Questionnaires</topic><topic>Rabies</topic><topic>Rabies - prevention &amp; control</topic><topic>Rabies Vaccines - economics</topic><topic>Rabies Vaccines - therapeutic use</topic><topic>Regression analysis</topic><topic>Risk analysis</topic><topic>Risk Factors</topic><topic>Schedules</topic><topic>Senegal</topic><topic>Sex ratio</topic><topic>Signs and symptoms</topic><topic>Statistical analysis</topic><topic>Sub-saharan Africa</topic><topic>Tropical diseases</topic><topic>Vaccination</topic><topic>Vaccines</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Diallo, Mamadou Korka</creatorcontrib><creatorcontrib>Diallo, Alpha Oumar</creatorcontrib><creatorcontrib>Dicko, Anta</creatorcontrib><creatorcontrib>Richard, Vincent</creatorcontrib><creatorcontrib>Espié, Emmanuelle</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Gale In Context: Opposing Viewpoints</collection><collection>Gale In Context: Science</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Health and Safety Science Abstracts (Full archive)</collection><collection>Virology and AIDS Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Public Health Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>Directory of Open Access Journals</collection><jtitle>BMC infectious diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Diallo, Mamadou Korka</au><au>Diallo, Alpha Oumar</au><au>Dicko, Anta</au><au>Richard, Vincent</au><au>Espié, Emmanuelle</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Human rabies post exposure prophylaxis at the Pasteur Institute of Dakar, Senegal: trends and risk factors</atitle><jtitle>BMC infectious diseases</jtitle><addtitle>BMC Infect Dis</addtitle><date>2019-04-11</date><risdate>2019</risdate><volume>19</volume><issue>1</issue><spage>321</spage><epage>9</epage><pages>321-9</pages><artnum>321</artnum><issn>1471-2334</issn><eissn>1471-2334</eissn><abstract>Rabies remains a major public health problem in developing countries. Most fatal rabies cases, especially in children, result from dog bites and occur in low-income countries, such as those in Sub-Saharan Africa. Rabies can be controlled through mass dog vaccination and human deaths prevented through timely and appropriate post-exposure prophylaxis (PEP). As access to appropriate PEP remains a serious challenge for bite-victims, the aim of this study was to understand the use of PEP, to evaluate the knowledge, attitudes and practices with respect to rabies and to identify risk factors related to non-compliance with PEP to define recommendations for improving PEP in Senegal. This study included patients with suspicion of rabies exposure who sought PEP at the Pasteur Institute of Dakar from April 2013 to March 2014. Patients with rabies clinical symptoms, those who had already started PEP and those with exposure outside Senegal or for more than 3 months were excluded. Data on risk factors and propensity to seek and complete PEP were collected using questionnaires and phone interviews. The association between acceptability and compliance with PEP and other independent variables were evaluated using multivariate regression analysis. Among the 905 patients enrolled into the study, 67% were male (sex ratio M/F, 2) and 46%, children under 15 years of age. Exposures by animal bites represented 87%, whereas the remainder were due to scratches or contact; 76% were classified as WHO category III and 88% were due to dogs. Among these patients, 7% refused to start PEP and 54.5% completed the full schedule. Main factors reported by non-compliant patients were vaccine costs and affordability, and knowledge on status of biting animal. This study shows that despite the awareness about rabies dangers and prevention, only half of the patients completed the full PEP schedule. The following recommendations, such as free of charge prophylaxis or intradermal regimens as an alternative to intramuscular regimens, should be considered to increase the adherence to PEP at the Pasteur Institute of Dakar and in Senegal.</abstract><cop>England</cop><pub>BioMed Central Ltd</pub><pmid>30975098</pmid><doi>10.1186/s12879-019-3928-0</doi><tpages>9</tpages><orcidid>https://orcid.org/0000-0001-8697-7880</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1471-2334
ispartof BMC infectious diseases, 2019-04, Vol.19 (1), p.321-9, Article 321
issn 1471-2334
1471-2334
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_598ac729ef6c473492f597fa47635088
source Publicly Available Content Database; PubMed Central
subjects Adolescent
Adult
Aged
Aged, 80 and over
Analysis
Animal bites
Animals
Bites (Injuries)
Bites and Stings
Biting
Child
Child, Preschool
Children
Cohort Studies
Costs and Cost Analysis
Developing Countries
Dog bites
Dogs
Exposure
Female
Health Knowledge, Attitudes, Practice
Humans
Immunization
Independent variables
Infant
Infectious diseases
Knowledge
LDCs
Male
Medical research
Middle Aged
Patient Compliance
Patients
Post exposure prophylaxis
Post-Exposure Prophylaxis - methods
Post-Exposure Prophylaxis - trends
Prophylaxis
Prospective Studies
Public health
Questionnaires
Rabies
Rabies - prevention & control
Rabies Vaccines - economics
Rabies Vaccines - therapeutic use
Regression analysis
Risk analysis
Risk Factors
Schedules
Senegal
Sex ratio
Signs and symptoms
Statistical analysis
Sub-saharan Africa
Tropical diseases
Vaccination
Vaccines
Young Adult
title Human rabies post exposure prophylaxis at the Pasteur Institute of Dakar, Senegal: trends and risk factors
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T22%3A17%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Human%20rabies%20post%20exposure%20prophylaxis%20at%20the%20Pasteur%20Institute%20of%20Dakar,%20Senegal:%20trends%20and%20risk%20factors&rft.jtitle=BMC%20infectious%20diseases&rft.au=Diallo,%20Mamadou%20Korka&rft.date=2019-04-11&rft.volume=19&rft.issue=1&rft.spage=321&rft.epage=9&rft.pages=321-9&rft.artnum=321&rft.issn=1471-2334&rft.eissn=1471-2334&rft_id=info:doi/10.1186/s12879-019-3928-0&rft_dat=%3Cgale_doaj_%3EA583177464%3C/gale_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c628t-a9c6fdae3eacf1d25f55a221a6be6936b53038fcdfd4d71901e9d71bd9c4c0013%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2211338760&rft_id=info:pmid/30975098&rft_galeid=A583177464&rfr_iscdi=true